Fertility warning
This medicine may affect fertility.
Leaflet DAUNORUBICINA KEMEX 20mg powder for solution for injection
- Product code:
- W69078001
- Quantity:
- 1
- Indicated for:
- leukemia
- Route of administration:
- injectable
- Substance:
- daunorubicin (antineoplastic agent)
- ATC
- L01DB02 — Antineoplastic and immunomodulating agents | Cytotoxic antibiotics and related substances | Anthracyclines and related substances
Precautions:
Dose adjustment in hepatic impairment
Dose adjustment may be needed in liver disease.
Cytotoxic / special handling
Handle with special care.
Contraception required
Effective contraception is required during treatment.
Contraindicated during breastfeeding
Do not use this medicine while breastfeeding.
Contraindicated during pregnancy
Do not use this medicine during pregnancy.
Hepatotoxicity
This medicine may affect the liver.
Major drug interactions
This medicine may have important interactions with other medicines.
Myelosuppression / agranulocytosis
This medicine may lower blood cell counts.
Additional monitoring
This medicine is subject to additional monitoring.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Severe skin reactions
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Daunorubicin is a chemotherapy drug used for the treatment of acute leukemia, including acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). It belongs to the anthracycline class and works by inhibiting DNA synthesis in cancer cells, preventing their division.
The medication is administered intravenously and is often used in combination with other chemotherapy drugs to enhance treatment effectiveness. It is effective in inducing remission in patients with acute leukemia.
Side effects may include nausea, vomiting, hair loss, bone marrow suppression, and an increased risk of infections. In rare cases, it may cause cardiac toxicity. Close monitoring is essential during treatment.
Consult your doctor to discuss the benefits and risks of treatment with Daunorubicin. Follow all medical recommendations to minimize associated risks.
The medication is administered intravenously and is often used in combination with other chemotherapy drugs to enhance treatment effectiveness. It is effective in inducing remission in patients with acute leukemia.
Side effects may include nausea, vomiting, hair loss, bone marrow suppression, and an increased risk of infections. In rare cases, it may cause cardiac toxicity. Close monitoring is essential during treatment.
Consult your doctor to discuss the benefits and risks of treatment with Daunorubicin. Follow all medical recommendations to minimize associated risks.
General data about DAUNORUBICINA KEMEX 20mg
- Substance:
- daunorubicin
- Date of latest medicines list:
- 01-09-2025
- Product code:
- W69078001
- Concentration:
- 20mg
- Pharmaceutical form:
- powder for solution for injection
- Quantity:
- 1
- Product type:
- Generic medicine
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for daunorubicin
Concentrations available for daunorubicin
- 20mg
- 20mg/10ml